Walgreens and Rite Aid followed CVS Pharmacy in halting Zantac sales after the FDA flagged a possible carcinogen in the heartburn drug.
Walgreens temporarily removed the drug from its shelves Sept. 30 "while the FDA continues its review of the products," a company spokesperson told The New York Times.
Rite Aid is also removing Zantac and other generic ranitidine products from its shelves, The New York Times reports.
Both companies said Zantac bought at their drugstores could be returned for a refund.
Read the full article here.
More articles on pharmacy:
World Pharmacist Day promotes use of safe and effective medicines
USP delays release of updated compounding standards
Americans pay up to 67 times more for drugs than other countries.